Warning to women amid shortages of some HRT products

• Two commonly prescribed HRT patch brands (Estradot and FemSeven Conti) are currently in short supply across the UK, requiring proactive management of patient prescriptions.
• Clinicians should consider alternative HRT formulations or brands with adequate stock availability to maintain continuity of care for patients already established on these products.
• The Department of Health has issued this warning to enable early planning; GPs should check stock status with pharmacies and discuss options with patients to avoid treatment interruption.

Two brands of HRT patches, including Estradot transdermal and FemSeven Conti patches, have been affected, the Department of Health has said.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.